Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Instinctif Partners Public Affairs Ireland .
Filed returns
57
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to the Minister for Health, Stephen Donnelly TD, regarding the Bolar clause of the EU Pharmaceutical Legislation. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to Robert Watt regarding the implications of the Urban Waste Water Treatment Directive for the biosimilar, generic and off-patent medicines industry. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to Niall Redmond regarding the arrangement of an in-person meeting. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to political stakeholders regarding MFI's General Election Manifesto. (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to political representatives regarding the implications of the Urban Waste Water Treatment Directive for the biosimilar, generic and off-patent medicines industry. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss the EU pharmaceutical directive (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss the Urban Wastewater Treatment Directive (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss coordination of national stockpiling measures to prevent medicine shortages. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss the Health (Miscellaneous Provisions) Bill 2024 (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Follow up to the annual Medicines for Europe 2024 conference 12-13 June in Dublin (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss Per- and polyfluoroalkyl substances (PFAS) chemicals and the impact on the generic, biosimilar and value added medicines industry. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Meeting request regarding the unified position taken by the HSE placing an across-the-board price freeze on all regulated and non-regulated goods and services without giving due consideration to the impact this will… (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Invitation to the Medicines for Europe 18th Legal Affairs Conference 10-11 June in Dublin (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Invitation to the annual Medicines for Europe 2024 conference: 12 - 13 June in Dublin (Public policy or programme) | 22 | On lobbying.ie |
| Jan–Apr 2024 | Instinctif Partners Public Affairs Ireland | Health | Communication regarding Minister Donnelly's available to provide an opening address to the annual Medicines for Europe 2024 conference - 12 - 13 June in Dublin (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Instinctif Partners Public Affairs Ireland | Health | Invitation to provide an address at the annual Medicines for Europe 2024 conference - 12 - 13 June in Dublin (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2024 | Instinctif Partners Public Affairs Ireland | Health | Communication regarding medicine repurposing as part of the revision of EU Pharmaceutical Legislation (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2024 | Instinctif Partners Public Affairs Ireland | Health | Communication regarding engagement with the Department of Health Taskforce on Productivity and Savings (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | Instinctif Partners Public Affairs Ireland | Health | Discuss EU legislative activities and the impact on the generics and biosimilar medicines (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2023 | Instinctif Partners Public Affairs Ireland | Health | To discuss the MFI pre-budget submission 2024 (Public policy or programme) | 28 | On lobbying.ie |
| May–Aug 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagement with Irish and EU policy makers regarding EU regulation affecting pressurised Metered Dose Inhalers (pMDIs) (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Shared Medicines for Europe letter to key EU figures ahead of EPSCO meeting on Health (14th March) (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagment with the Department with respect to the review of goverance of drug reimbursement processes and recommendations set out in the Mazars Report (published 24/02/23). (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagement with the Department of Health regarding the review of governance arrangements to support HSE drug reimbursement process (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Notification of MFI lessons learned from Covid-19 Report in the context of upcoming Government inquiry into Covid-19, in order to raise awareness of medicines shortages in Ireland and the sustainable supply of medicines… (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagement with Irish and EU policy makers regarding EU regulation affecting pressurised Metered Dose Inhalers (pMDIs) (Public policy or programme) | 34 | On lobbying.ie |
| Sep–Dec 2022 | Instinctif Partners Public Affairs Ireland | Health | Engagement with the Department of Health in order to raise awareness of medicines shortages in Ireland and the sustainable supply of medicines in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2022 | Instinctif Partners Public Affairs Ireland | Health | Notification of MFI 2023 Pre Budget Submission to all members of the Oireachtas Health Committee and relevant Ministers in order to raise awareness of medicines shortages in Ireland and the sustainable supply of… (Public policy or programme) | 17 | On lobbying.ie |
| May–Aug 2022 | Instinctif Partners Public Affairs Ireland | Health | Invitation to participate as guest speaker at Medicines for Ireland (MFI) Generics Day virtual event (16th of June 2022) (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2021 | Instinctif Partners Public Affairs Ireland | Health | The implementation of the Protocol on Ireland and Northern Ireland (“IE/NI Protocol”) concerning the location of the Marketing Authorisation Holder (“MAH”) (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2021 | Instinctif Partners Public Affairs Ireland | Health | Value Added Medicines Report "Discussion document on the contribution of Value Added Medicines in Ireland" (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2021 | Instinctif Partners Public Affairs Ireland | Health | Communication from AAIIS in support of amendments to the Health Insurance (Amendment) Bill 2021 (Legislation) | 14 | On lobbying.ie |
| Sep–Dec 2021 | Instinctif Partners Public Affairs Ireland | Health | To discuss the upcoming Framework Agreement on the Supply and Pricing of Medicines, including published reports from Medicines for Ireland in relation to Generic Medicines, Biosimilar Medicines and Value Added Medicines… (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2021 | Instinctif Partners Public Affairs Ireland | Health | Invitation to speak at the Generic Medicines Day virtual event (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2021 | Instinctif Partners Public Affairs Ireland | Health | To discuss the upcoming Framework Agreement on the Supply and Pricing of Medicines (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2021 | Instinctif Partners Public Affairs Ireland | Health | Invitation to speak at the Generic Medicines Day virtual event (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2021 | Instinctif Partners Public Affairs Ireland | Health | To highlight the impact of Covid mandatory hotel quarantine on essential workers who support the production of medicines and medicial devices (Public policy or programme) | 13 | On lobbying.ie |
| Jan–Apr 2021 | Instinctif Partners Public Affairs Ireland | Health | To submit the contents of the "Filling the Gap" Report relating to how off patent medicines can improve the equity and quality of cancer care (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Instinctif Partners Public Affairs Ireland | Health | To submit recent Medicines for Ireland (MFI) reports, "Ireland's Patients First" and the "Lessons Learned from COVID-19" report (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Instinctif Partners Public Affairs Ireland | Health | Meeting to discuss medicines supply and Brexit (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2020 | Instinctif Partners Public Affairs Ireland | Education and Training | To raise the issue of the threat to the continued availability of non-community rated student medical insurance for international students studying in Ireland (Public policy or programme) | 31 | On lobbying.ie |
| May–Aug 2020 | Instinctif Partners Public Affairs Ireland | Health | To raise the issue of the threat to the continued availability of non-community rated student medical insurance for international students studying in Ireland (Legislation) | 20 | On lobbying.ie |
| May–Aug 2020 | Instinctif Partners Public Affairs Ireland | Health | Policy update re Covid-19 and supply of medicines (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2020 | Instinctif Partners Public Affairs Ireland | EU Affairs | Discuss the need for a Mutual Recognition Agreement between the EU and UK (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2020 | Instinctif Partners Public Affairs Ireland | Health | Policy update re Brexit and the supply of medicines in Ireland (Public policy or programme) | 22 | On lobbying.ie |
| May–Aug 2020 | Instinctif Partners Public Affairs Ireland | Health | To discuss the contents of MFI's report: Ireland's Patients First 2020-2022 (Public policy or programme) | 17 | On lobbying.ie |
| May–Aug 2020 | Instinctif Partners Public Affairs Ireland | Health | Policy update re national supply and pricing agreement for medicines (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2020 | Instinctif Partners Public Affairs Ireland | EU Affairs | Policy update re Brexit and the supply of medicines in Ireland (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2020 | Instinctif Partners Public Affairs Ireland | Health | Policy update re Covid-19 and supply of medicines; update re national supply and pricing agreement for medicines (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2020 | Instinctif Partners Public Affairs Ireland | Health | Policy update re the European Union Employment, Social Policy, Health and Consumer Affairs Council (Public policy or programme) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 53 | 93.0% | |
| EU Affairs | 2 | 3.5% | |
| Agriculture | 1 | 1.8% | |
| Education and Training | 1 | 1.8% |